Steroid response and outcomes in childhood nephrotic syndrome: A multicenter, cross-sectional study from Jordan

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 4

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Pediatrics

ISSN

2219-2808

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Clin Pediatr. Dec 9, 2025; 14(4): 109671
Published online Dec 9, 2025. doi: 10.5409/wjcp.v14.i4.109671

Table 4 Steroid-sparing medications, n (%)

Medication	Patients received steroid-sparing medications, n = 51
Cyclosporine	26 (51.0)
Tacrolimus	1 (2.0)
Mycophenolate	20 (39.2)
Cyclophosphamide	1 (2.0)
Levamisole	3 (5.9)

Citation: Ajarmeh SA, Akl K, Al Shawabkeh M, Al Baramki J. Steroid response and outcomes in childhood nephrotic syndrome: A multicenter, cross-sectional study from Jordan. World J Clin Pediatr 2025; 14(4): 109671
URL: https://www.wjgnet.com/2219-2808/full/v14/i4/109671.htm
DOI: https://dx.doi.org/10.5409/wjcp.v14.i4.109671

Ajarmeh SA, Akl K, Al Shawabkeh M, Al Baramki J. Steroid response and outcomes in childhood nephrotic syndrome: A multicenter, cross-sectional study from Jordan. World J Clin Pediatr 2025; 14(4): 109671 [PMID: 41255701 DOI: 10.5409/wjcp.v14.i4.109671]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.